In Part 1,
we looked at the various steps involved in a merger, acquisition, or
going private transaction. As the transaction progresses along those
steps, the spread between the market price and the closing price tends
to close as the transaction becomes more finalized and less risky. In Part 2, we looked at a few deals and analyzed the risk vs. reward as well as the need to really dig in to the SEC filings.
Workouts are meant to be virtually "risk-less" transactions for idle cash in your portfolio. Let's dive in with that in mind.
The lists below, with data from StockVal, are comprised of domestic companies primarily with market caps in excess of $50mm, ranked by the return this past week. If the reader believes that there are erroneous inclusions or exclusions, feel free to
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
.
There were even fewer outliers in this holiday-shortened week, with 4 double-digit gainers and just one double-digit decliner....
According to the American Cancer Society, one in three Americans will develop some form of cancer in their lifetime.
Radiation Therapy Services Inc. (Nasdaq: RTSX) is a national operator of radiation therapy centers with 1,240 employees that has treated cancer patients for 24 years. With 80 locations in 16 states (many under the name of 21st Century Oncology), the company\'s facilities provide treatments to some 1,600 patients daily, offering them a broad spectrum of conventional and alternative radiation therapy services. Radiation Therapy Services also runs the Radiation Therapy School for Radiation Technology, a training center for oncology radiation therapists in Cape...
Alan Brochstein, CFA submits:
After plunging in the week following ASCO and then underperforming the following week, cancer stocks were hammered yet again.
The list below, with data from StockVal, is comprised of domestic companies primarily with market caps in excess of $50mm, ranked by the return this past week.
The 14 double-digit declines exceeded the 12 that plunged immediately following the ASCO meeting, with just a single double-digit gainer. The median return of -4.2% and the average...
Jordan Kahn submits: I have been bullish on the cancer treatment stock, Radiation Therapy Services (RTSX), as the company has good growth and strong fundamentals. But the stock has been mired in a downtrend that has been troubling.
It is sometimes painful watching and waiting for a stock to bottom, but I have held off adding to this position until I see some signs of stabilization.
Alan Brochstein, CFA submits:
After plunging in the week following ASCO, cancer-related stocks merely underperformed this week.
The list below, with data from StockVal, is comprised of domestic companies primarily with market caps in excess of $50mm, ranked by the return this past week.
The number of double-digit declines decreased from 12 to just 4, but there were no double-digit gainers. The median return of 0.0 and the average return of -0.3 trailed the S&P 500 significantly (-1.6% and -2% respectively)....
Alan Brochstein, CFA submits:
Cancer-related stocks soared during the holiday-shortened week as presentations began on June 1st at the ASCO annual meeting in Chicago.
Last week?s big winner, Bioenvision (BIVN), received an offer from partner Genzyme (GENZ) at a disappointing premium but well ahead of multi-year lows reached in early May.
The list below is comprised of domestic companies primarily with market caps in excess of $50mm, ranked by the return this past week.
Alan Brochstein, CFA submits:
Later this week, the big event of the year for companies trying to treat cancer takes place in Chicago: the American Society of Clinical Oncology?s Annual Meeting. Not surprisingly, the universe of cancer stocks performed well in a rather lackluster week for the market.
I recently created a list of companies with market capitalization in excess of $50mm at the beginning of May that derive a significant amount of their market value from cancer-related pursuits. ...
SAN FRANCISCO (MarketWatch) -- Shares of the following companies were among those making percentage moves of 5% or more in the U.S. stock market Monday.
Stocks 
